Amgen Inc. buy Royal Bank of Canada
Start price
14.06.24
/
50%
€278.00
Target price
14.06.25
€310.92
Performance (%)
-7.41%
End price
15.06.25
€257.40
Summary
This prediction ended on 15.06.25 with a price of €257.40. With a performance of -7.41%, the BUY prediction by Royal_Bank_of_Canada finished with a loss. Royal_Bank_of_Canada has a follow-up prediction for Amgen Inc. where he still thinks Amgen Inc. is a Buy. A total of €8.81 was paid as dividends for this prediction. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Amgen Inc. | 3.334% | 3.334% | 11.809% |
| iShares Core DAX® | -0,38 % | 1,09 % | 11,64 % |
| iShares Nasdaq 100 | -0,41 % | -1,97 % | 7,27 % |
| iShares Nikkei 225® | 1,84 % | 10,26 % | 31,38 % |
| iShares S&P 500 | -0,71 % | 0,44 % | 4,30 % |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Amgen Inc. diskutieren
Amgen Inc. (NASDAQ: AMGN) had its price target raised by analysts at Royal Bank of Canada from $328.00 to $332.00. They now have an "outperform" rating on the stock.
Ratings data for AMGN provided by MarketBeat
In the thread Trading Amgen Inc.
Die von Royal_Bank_of_Canada gewählte maximale Laufzeit wurde überschritten